Charles Schwab’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $42.2K | Hold |
12,785
| – | – | ﹤0.01% | 3460 |
|
|
2025
Q1 | $36.6K | Hold |
12,785
| – | – | ﹤0.01% | 3433 |
|
|
2024
Q4 | $29.7K | Hold |
12,785
| – | – | ﹤0.01% | 3472 |
|
|
2024
Q3 | $40.3K | Hold |
12,785
| – | – | ﹤0.01% | 3436 |
|
|
2024
Q2 | $28.3K | Hold |
12,785
| – | – | ﹤0.01% | 3568 |
|
|
2024
Q1 | $39.9K | Hold |
12,785
| – | – | ﹤0.01% | 3385 |
|
|
2023
Q4 | $49.6K | Hold |
12,785
| – | – | ﹤0.01% | 3404 |
|
|
2023
Q3 | $41.8K | Hold |
12,785
| – | – | ﹤0.01% | 3420 |
|
|
2023
Q2 | $40.9K | Hold |
12,785
| – | – | ﹤0.01% | 3443 |
|
|
2023
Q1 | $55K | Hold |
12,785
| – | – | ﹤0.01% | 3333 |
|
|
2022
Q4 | $54.3K | Hold |
12,785
| – | – | ﹤0.01% | 3337 |
|
|
2022
Q3 | $63K | Sell |
12,785
-11,431
| -47% | -$56.3K | ﹤0.01% | 3275 |
|
|
2022
Q2 | $75K | Buy |
+24,216
| New | +$75K | ﹤0.01% | 3319 |
|